These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. FDG PET of the brain in pediatric patients: imaging spectrum with MR imaging correlation. Stanescu L; Ishak GE; Khanna PC; Biyyam DR; Shaw DW; Parisi MT Radiographics; 2013; 33(5):1279-303. PubMed ID: 24025925 [TBL] [Abstract][Full Text] [Related]
9. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging. Ozsunar Y; Mullins ME; Kwong K; Hochberg FH; Ament C; Schaefer PW; Gonzalez RG; Lev MH Acad Radiol; 2010 Mar; 17(3):282-90. PubMed ID: 20060750 [TBL] [Abstract][Full Text] [Related]
10. A Mass With High Uptake of Fluorodeoxyglucose on Positron Emission Tomography. Staals EL; Rimondi E; Palmerini E JAMA Oncol; 2018 Oct; 4(10):1421-1422. PubMed ID: 29800047 [No Abstract] [Full Text] [Related]
11. Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study. Morana G; Piccardo A; Puntoni M; Nozza P; Cama A; Raso A; Mascelli S; Massollo M; Milanaccio C; Garrè ML; Rossi A Neuro Oncol; 2015 Dec; 17(12):1637-47. PubMed ID: 26405202 [TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Rachinger W; Goetz C; Pöpperl G; Gildehaus FJ; Kreth FW; Holtmannspötter M; Herms J; Koch W; Tatsch K; Tonn JC Neurosurgery; 2005 Sep; 57(3):505-11; discussion 505-11. PubMed ID: 16145529 [TBL] [Abstract][Full Text] [Related]
13. Neuroimaging in pediatric epilepsy: a multimodality approach. Rastogi S; Lee C; Salamon N Radiographics; 2008; 28(4):1079-95. PubMed ID: 18635630 [TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system lymphoma and glioblastoma: differentiation using dynamic susceptibility-contrast perfusion-weighted imaging, diffusion-weighted imaging, and (18)F-fluorodeoxyglucose positron emission tomography. Nakajima S; Okada T; Yamamoto A; Kanagaki M; Fushimi Y; Okada T; Arakawa Y; Takagi Y; Miyamoto S; Togashi K Clin Imaging; 2015; 39(3):390-5. PubMed ID: 25547624 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme. Yamashita K; Hiwatashi A; Togao O; Kikuchi K; Kitamura Y; Mizoguchi M; Yoshimoto K; Kuga D; Suzuki SO; Baba S; Isoda T; Iwaki T; Iihara K; Honda H J Magn Reson Imaging; 2016 Nov; 44(5):1256-1261. PubMed ID: 27093558 [TBL] [Abstract][Full Text] [Related]
17. Emerging techniques and technologies in brain tumor imaging. Ellingson BM; Bendszus M; Sorensen AG; Pope WB Neuro Oncol; 2014 Oct; 16 Suppl 7(Suppl 7):vii12-23. PubMed ID: 25313234 [TBL] [Abstract][Full Text] [Related]
18. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
19. ¹⁸F-fluorodeoxyglucose PET/computed tomography for primary brain tumors. Segtnan EA; Hess S; Grupe P; Høilund-Carlsen PF PET Clin; 2015 Jan; 10(1):59-73. PubMed ID: 25455880 [TBL] [Abstract][Full Text] [Related]
20. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses. Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]